---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-148851"
form_type: "8-K"
ticker: "NEOG"
cik: "0000711377"
company_name: "NEOGEN CORP"
filed_at: "2026-04-09T23:59:59+00:00"
generated_at: "2026-05-15T06:50:57.826691+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Neogen Q3 FY26 revenue $211.2M; net loss $17M; divests Genomics unit

## Summary
- Revenue $211.2M; Food Safety core growth +4.0%, Animal Safety core growth –8.7% on supplier challenges.
- GAAP net loss $17.0M ($0.08 loss per share); Adjusted EPS $0.09; Adjusted EBITDA $48.2M (22.8% margin).
- Divestiture of Genomics business announced, expected to close in Q2 FY27; proceeds to reduce leverage.
- Raising FY2026 revenue outlook; maintaining Adjusted EBITDA guidance.
- Petrifilm manufacturing transition on track for November FY27; validation on multiple SKUs started.

## SEC filing metadata
- accession: 0001193125-26-148851
- form_type: 8-K
- ticker: NEOG
- cik: 0000711377
- company_name: NEOGEN CORP
- filed_at: 2026-04-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711377/000119312526148851/0001193125-26-148851-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711377/000119312526148851/neog-20260409.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-148851
- JSON: https://secwatch.observer/filing/0001193125-26-148851.json
- Plain text: https://secwatch.observer/filing/0001193125-26-148851.txt

## Key facts
- Earnings Releases
  NEOGEN CORP reported third quarter ended February 28, 2026 results: revenue $211.2 million, net income Net loss of $17.0 million, EPS GAAP EPS of $(0.08). Guidance raised.
  - Period: third quarter ended February 28, 2026
  - Revenue: $211.2 million
  - Net income: Net loss of $17.0 million
  - EPS: GAAP EPS of $(0.08)
  - Guidance: raised
  - Result: preliminary results
  source text: language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Reports Third Quarter Fiscal Year 2026 Financial Results • Fiscal third quarter 2026 revenue of $211.2 million • Food Safety revenue growth of 2.6%, Core Growth 1 of 4.0%; Animal Safety revenue growth of (20.1%), Core Growth 1 of (8.7%) due primarily to third-party supplier challenges in
  evidence_url: https://www.sec.gov/Archives/edgar/data/711377/000119312526148851/0001193125-26-148851-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.